What Will It Take to Control Continuous Biomanufacturing? - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

What Will It Take to Control Continuous Biomanufacturing?

  • November 2, 2026

  • 3 min

Share

Objective:

The article examines the objective, findings, and clinical context described in What Will It Take to Control Continuous Biomanufacturing?.

Approach:
  • Control methods: The review contrasts conventional PID control for stable, directly measured variables with model predictive control (MPC), which can forecast behavior and adjust multiple inputs under constraints.
  • Measurement and estimation: It discusses process analytical technology, in-line and online sensors, at-line sampling, and soft sensors for estimating attributes that cannot be measured directly.
  • Emerging tools and implementation: The review considers reinforcement learning and digital twins, and proposes a gradual path from decision support to supervisory optimization and controlled adjustments.
Key Findings:
  • Continuous processes must stay within operating and quality limits over extended periods while responding to disturbances, equipment drift, and interactions between connected operations.
  • PID control is suited to stable, clearly measured variables but is less effective when variables interact or measurements are delayed; MPC can address more complex, constrained control problems.
  • In a cited six-day filtration study, model-guided feedback control kept monoclonal antibody concentrations within 0.5–2.5% of setpoints and buffer exchange within 8% of its target.
  • Sensors can be costly to install and maintain and may experience calibration drift. At-line or automated sampling may be adequate for slower processes.
  • Soft-sensor estimates can be affected by sensor noise and model error, potentially leading to inappropriate control actions.
  • Reinforcement learning remains largely at the simulation and laboratory-demonstration stage; limited training data, safety and regulatory concerns, and low interpretability are barriers.
  • Digital twins could support testing, optimization, and algorithm training in a virtual environment.
Interpretation:

The review characterizes continuous biomanufacturing as a process-control and system-integration challenge. It proposes gradual implementation of digital-twin-supported control and states that advanced systems should be justified by measurable improvements in product recovery, consistency, or risk management.

Limitations:
  • The context does not provide the review's authors, publication details, or a source URL.
  • The cited filtration performance is one study example and does not establish performance across other processes.
  • Reinforcement learning is described as largely limited to simulations and laboratory demonstrations.

Original Source(s)

Related Content